Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic BRCA-Associated Breast Carcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Brain|Metastatic Triple-Negative Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast Cancer AJCC v6 and v7
Interventions: DRUG: Cisplatin|OTHER: Laboratory Biomarker Analysis|OTHER: Placebo Administration|DRUG: Veliparib
Sponsor: National Cancer Institute (NCI)